Final Results of a Phase I/II Trial of the Combination of Concurrent Lenalidomide, Thalidomide and Dexamethasone in Patients with Relapsed and/or Refractory Myeloma
暂无分享,去创建一个
Michael L. Wang | S. Parmar | R. Orlowski | U. Popat | Q. Bashir | M. Qazilbash | R. Champlin | Sheeba K. Thomas | J. Shah | D. Weber | N. Shah | R. Alexanian